Comparative effectiveness of metformin versus sulfonylureas on kidney function decline or death among patients with reduced kidney function: a retrospective cohort study

Adriana M. Hung; Amber J. Hackstadt; Marie R. Griffin; Carlos G. Grijalva; Robert A. Greevy; Christianne L. Roumie

doi:10.9778/cmajo.20210207

Article Information

vol. 11 no. 1 E77-E89

DOI

https://doi.org/10.9778/cmajo.20210207

PubMed

36720491

History

Published online January 31, 2023.

© 2023 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/

Author Information

Adriana M. Hung, MD MPH,
Amber J. Hackstadt, PhD,
Marie R. Griffin, MD MPH,
Carlos G. Grijalva, MD MPH,
Robert A. Greevy Jr., PhD,
Christianne L. Roumie, MD MPH

Department of Medicine, Division of Nephrology and Hypertension (Hung), Vanderbilt University Medical Center; Precision Nephrology Program (Hung), Vanderbilt University Medical Center; Geriatric Research Education Clinical Center (Hung, Hackstadt, Grijalva, Greevy Jr., Roumie), Veteran Administration Tennessee Valley Healthcare System; Department of Medicine (Roumie), Vanderbilt University Medical Center; Department of Biostatistics (Hackstadt, Greevy Jr.), Vanderbilt University School of Medicine; Department of Health Policy (Griffin, Grijalva, Roumie), Vanderbilt University Medical Center, Nashville, Tenn.